TP53 and neoplasm: In another study, Shah and colleagues sequenced and analysed more than 100 TNBC tumours at the time of diagnosis and confirmed the high rate of TP53 mutations, although 12% of tumours did not show somatic mutations in any established driver genes, suggesting that primary TNBCs are mutationally heterogeneous from the outset [10, 28].